Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of Human Adrenocortical Adenoma (HAA1) Cell Line from Zona Reticularis. | Int J Mol Sci | 2022 | 36614027 | PubTator, text mining | PubMed |
| Epimutations and Their Effect on Chromatin Organization: Exciting Avenues for Cancer Treatment. | Cancers (Basel) | 2022 | 36612210 | PubTator, text mining | PubMed |
| Hsa_circ_0015278 Regulates FLT3-ITD AML Progression via Ferroptosis-Related Genes. | Cancers (Basel) | 2022 | 36612069 | PubTator, text mining | PubMed |
| Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies. | Cancers (Basel) | 2022 | 36612019 | PubTator, text mining | PubMed |
| Modeling neuromuscular diseases in zebrafish. | Front Mol Neurosci | 2022 | 36583079 | PubTator, text mining | PubMed |
| Non-coding RNAs: Role in diabetic foot and wound healing. | World J Diabetes | 2022 | 36578864 | PubTator, text mining | PubMed |
| BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death. | Cell Commun Signal | 2022 | 36575468 | PubTator, text mining | PubMed |
| Histone modification of endothelial-mesenchymal transition in cardiovascular diseases. | Front Cardiovasc Med | 2022 | 36568553 | PubTator, text mining | PubMed |
| Harnessing the cyclization strategy for new drug discovery. | Acta Pharm Sin B | 2022 | 36562004 | PubTator, text mining | PubMed |
| Exosomes Released by Influenza-Virus-Infected Cells Carry Factors Capable of Suppressing Immune Defense Genes in Naïve Cells. | Viruses | 2022 | 36560694 | PubTator, text mining | PubMed |
| Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. | Pharmaceutics | 2022 | 36559094 | PubTator, text mining | PubMed |
| Therapeutic Efficacy of Novel HDAC Inhibitors SPA3052 and SPA3074 against Intestinal Inflammation in a Murine Model of Colitis. | Pharmaceuticals (Basel) | 2022 | 36558966 | PubTator, text mining | PubMed |
| Target Identification of 22-(4-Pyridinecarbonyl) Jorunnamycin A, a Tetrahydroisoquinoline Derivative from the Sponge Xestospongia sp., in Mediating Non-Small-Cell Lung Cancer Cell Apoptosis. | Molecules | 2022 | 36558080 | PubTator, text mining | PubMed |
| Sex differences in early and term placenta are conserved in adult tissues. | Biol Sex Differ | 2022 | 36550527 | PubTator, text mining | PubMed |
| A comparative quantitative structural assessment of benzothiazine-derived HDAC8 inhibitors by predictive ligand-based drug designing approaches. | SAR QSAR Environ Res | 2022 | 36533308 | PubTator, text mining | PubMed |
| Integrating the tumor-suppressive activity of Maspin with p53 in retuning the epithelial homeostasis: A working hypothesis and applicable prospects. | Front Oncol | 2022 | 36523976 | PubTator, text mining | PubMed |
| Histone acetylation modifications: A potential targets for the diagnosis and treatment of papillary thyroid cancer. | Front Oncol | 2022 | 36523971 | PubTator, text mining | PubMed |
| Case report: A novel heterozygous synonymous variant in deep exon region of NIPBL gene generating a non-canonical splice donor in a patient with cornelia de lange syndrome. | Front Genet | 2022 | 36506332 | PubTator, text mining | PubMed |
| Potential of histone deacetylase inhibitors for the therapy of ovarian cancer. | Front Oncol | 2022 | 36505774 | PubTator, text mining | PubMed |
| Azumamides A-E: Isolation, Synthesis, Biological Activity, and Structure-Activity Relationship. | Molecules | 2022 | 36500529 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=26